NCT02132234

Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Jagiellonian University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to evaluate the influence of anti tumor necrosis factor-alpha (TNF-α) treatment on blood pressure, endothelial function and immune cell phenotype in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Conditions

• Rheumatoid Arthritis
• Psoriatic Arthritis
• Ankylosing Spondylitis
• Hypertension

Interventions

Type	Name	Description
DRUG	Etanercept	biological treatment according to rheumatologic indication
DRUG	Adalimumab	biological treatment according to rheumatologic indication
DRUG	Certolizumab	biological treatment according to rheumatologic indication
DRUG	Infliximab	biological treatment according to rheumatologic indication

Timeline

• Start date: 2013-06-01
• Primary completion: 2014-07-01
• First posted: 2014-05-07
• Last updated: 2014-05-07

Locations

1 site across 1 country: Poland